Ng W, Soo K, Huynh H
Int J Mol Sci. 2024; 25(3).
PMID: 38338842
PMC: 10855313.
DOI: 10.3390/ijms25031563.
Elhemely M, Belgath A, El-Sayed S, Burusco K, Kadirvel M, Tirella A
J Med Chem. 2022; 65(6):4783-4797.
PMID: 35290041
PMC: 9098178.
DOI: 10.1021/acs.jmedchem.1c01936.
Kohler L, Reich S, Begemann G, Schobert R, Biersack B
ChemMedChem. 2022; 17(10):e202200064.
PMID: 35226402
PMC: 9311119.
DOI: 10.1002/cmdc.202200064.
Ahmed S, Johnson R, Solanki R, Afewerki T, Wostear F, Warren D
Front Pharmacol. 2022; 13:836710.
PMID: 35153800
PMC: 8830533.
DOI: 10.3389/fphar.2022.836710.
Hijjawi M, Abutayeh R, Taha M
Molecules. 2020; 25(24).
PMID: 33353031
PMC: 7766225.
DOI: 10.3390/molecules25246003.
Synthesis and Evaluations of "1,4-Triazolyl Combretacoumarins" and Desmethoxy Analogues.
Khandaker T, Hess J, Aguilera R, Andrei G, Snoeck R, Schols D
European J Org Chem. 2019; 2019(33):5610-5623.
PMID: 31579393
PMC: 6774347.
DOI: 10.1002/ejoc.201900569.
Enhanced antitumor and anti-angiogenic effects of metronomic Vinorelbine combined with Endostar on Lewis lung carcinoma.
Qin R, Zhang Z, Zhu N, Chen F, Guo Q, Hu H
BMC Cancer. 2018; 18(1):967.
PMID: 30305062
PMC: 6180630.
DOI: 10.1186/s12885-018-4738-2.
The anti-angiogenic effect and novel mechanisms of action of Combretastatin A-4.
Su M, Huang J, Liu S, Xiao Y, Qin X, Liu J
Sci Rep. 2016; 6:28139.
PMID: 27338725
PMC: 4919637.
DOI: 10.1038/srep28139.
Safety and efficacy of salvage nano-particle albumin bound paclitaxel in recurrent cervical cancer: a feasibility study.
Minion L, Chase D, Farley J, Willmott L, Monk B
Gynecol Oncol Res Pract. 2016; 3:4.
PMID: 27231575
PMC: 4880945.
DOI: 10.1186/s40661-016-0025-6.
ZLM-7 exhibits anti-angiogenic effects via impaired endothelial cell function and blockade of VEGF/VEGFR-2 signaling.
Su M, Huang J, Li J, Qin X, Tang X, Jin F
Oncotarget. 2016; 7(14):19018-30.
PMID: 26967559
PMC: 4951348.
DOI: 10.18632/oncotarget.7968.
Halichondrin B amide acts as tubulin binding agent to exhibit anti-tumor efficacy in hematologic cancers.
Li Y, Zhang R, Yang Y, Li J, Zhu K, Yao K
Int J Clin Exp Med. 2016; 8(10):19662-9.
PMID: 26770630
PMC: 4694530.
Metronomic vinorelbine: Anti-angiogenic activity in vitro in normoxic and severe hypoxic conditions, and severe hypoxia-induced resistance to its anti-proliferative effect with reversal by Akt inhibition.
Mavroeidis L, Sheldon H, Briasoulis E, Marselos M, Pappas P, Harris A
Int J Oncol. 2015; 47(2):455-64.
PMID: 26095084
PMC: 4501653.
DOI: 10.3892/ijo.2015.3059.
Deoxypodophyllotoxin induces G2/M cell cycle arrest and apoptosis in SGC-7901 cells and inhibits tumor growth in vivo.
Wang Y, Xu Y, Jiang Z, Guerram M, Wang B, Zhu X
Molecules. 2015; 20(1):1661-75.
PMID: 25608854
PMC: 6272175.
DOI: 10.3390/molecules20011661.
Role of the microtubule-targeting drug vinflunine on cell-cell adhesions in bladder epithelial tumour cells.
Aparicio L, Castosa R, Haz-Conde M, Rodriguez M, Blanco M, Valladares M
BMC Cancer. 2014; 14:507.
PMID: 25012153
PMC: 4107965.
DOI: 10.1186/1471-2407-14-507.
Microtubule dynamics control tail retraction in migrating vascular endothelial cells.
Ganguly A, Yang H, Zhang H, Cabral F, Patel K
Mol Cancer Ther. 2013; 12(12):2837-46.
PMID: 24107446
PMC: 4011668.
DOI: 10.1158/1535-7163.MCT-13-0401.
Anti-migratory effect of vinflunine in endothelial and glioblastoma cells is associated with changes in EB1 C-terminal detyrosinated/tyrosinated status.
Rovini A, Gauthier G, Berges R, Kruczynski A, Braguer D, Honore S
PLoS One. 2013; 8(6):e65694.
PMID: 23750272
PMC: 3672205.
DOI: 10.1371/journal.pone.0065694.
Microvascular complications and diabetic retinopathy: recent advances and future implications.
Barot M, Gokulgandhi M, Patel S, Mitra A
Future Med Chem. 2013; 5(3):301-14.
PMID: 23464520
PMC: 3840430.
DOI: 10.4155/fmc.12.206.
The pharmacological bases of the antiangiogenic activity of paclitaxel.
Bocci G, Di Paolo A, Danesi R
Angiogenesis. 2013; 16(3):481-92.
PMID: 23389639
PMC: 3682088.
DOI: 10.1007/s10456-013-9334-0.
Concentration- and schedule-dependent effects of chemotherapy on the angiogenic potential and drug sensitivity of vascular endothelial cells.
Pasquier E, Tuset M, Street J, Sinnappan S, Mackenzie K, Braguer D
Angiogenesis. 2012; 16(2):373-86.
PMID: 23143659
PMC: 3595478.
DOI: 10.1007/s10456-012-9321-x.
Inhibition of SIRT2 potentiates the anti-motility activity of taxanes: implications for antineoplastic combination therapies.
Bonezzi K, Belotti D, North B, Ghilardi C, Borsotti P, Resovi A
Neoplasia. 2012; 14(9):846-54.
PMID: 23019416
PMC: 3459280.
DOI: 10.1593/neo.12728.